Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

The document discusses a young boy with autism and early puberty but does not provide a conclusion on managing his behavior.

The best treatments for slowing down pattern hair loss are minoxidil and finasteride, with some other drugs and hair transplantation also used.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Finasteride and minoxidil are approved treatments for hair loss, and hair transplants can be effective but require careful patient selection.

Avemor, a natural tonic made from aloe vera and moringa, was less effective than minoxidil in promoting hair growth on rabbits.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

The document concludes that injecting dutasteride into the skin (mesotherapy) can effectively treat common hair loss in both men and women.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Minoxidil is a primary treatment for hair loss but its exact working method is unknown.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Contraceptive agents help with menstrual issues, acne, and other health conditions in teens.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.